Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Greater occipital nerve block with lidocaine and methylprednisolone in chronic migraine
2014-001115-39Phase 4Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of lidocaine and methylprednisolone in chronic migraine (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Migraine-related disability. Started Sep 2015; status: terminated.
02
Drugs
lidocainemethylprednisolone
03
Conditions
chronic migraine
Beyond the preview
Go deeper on 2014-001115-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001115-39.